Discover 27 paid clinical trials in Gulfport, Mississippi. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 27
Active & Responsive
A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations
for
COVID-19
Location: 5 recruiting locations
Sponsor: ModernaTX, Inc.
Sex: All
Age: 12+
Code: NCT07089706
Recruiting
Active & Responsive
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
for
Lung Cancer Diagnosis
Location: 36 recruiting locations
Sponsor: Freenome Holdings Inc.
Sex: All
Age: 50+
Code: NCT06122077
Recruiting
Active & Responsive
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis
A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)
for
SARS-CoV-2
Location: 128 recruiting locations
Sponsor: ModernaTX, Inc.
Sex: All
Age: 50 - 64
Code: NCT07266558
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
for
Hypertension
Location: 28 recruiting locations
Sponsor: SoniVie Inc.
Sex: All
Age: 22 - 70+
Code: NCT06559891
Recruiting
New
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
for
Chronic Idiopathic Constipation (CIC)
Location: 32 recruiting locations
Sponsor: Ardelyx
Sex: All
Age: 18 - 70+
Code: NCT07382167
Phase3, Recruiting
An Observational Research Study for Cancer Patients on Immune Checkpoint Inhibitors, DiRECT Study
for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: 203 recruiting locations
Sponsor: University of Rochester NCORP Research Base
Sex: All
Age: 18+
Code: NCT05364086
Recruiting
A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities
for
Obesity, Overweight
Location: 12 recruiting locations
Sponsor: Eli Lilly and Company
Sex: All
Age: 12 - 17
Code: NCT06672939
Phase3, Recruiting
A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations